YUYUE MEDICAL(002223) 搜狐财经·2025-03-28 08:52Core Insights - Yuyue Medical's stock closed at 35.48 yuan, down 1.11%, with a rolling PE ratio of 20.48 times and a total market capitalization of 35.568 billion yuan [1] - The average PE ratio for the medical device industry is 45.22 times, with a median of 32.57 times, placing Yuyue Medical at the 42nd position in the industry ranking [1] - As of February 28, 2025, Yuyue Medical had 40,000 shareholders, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Company Overview - Jiangsu Yuyue Medical Equipment Co., Ltd. specializes in the research, manufacturing, and sales of medical devices, along with providing related solutions [1] - The company's product range includes respiratory oxygen, diabetes care, infection control solutions, home electronic testing, in vitro diagnostics, emergency and clinical rehabilitation devices [1] - Yuyue Medical owns several major brands, including "Yuyue," "Jiefuro," "Huatuo," "Jinzhong," "An'er iodine," "Primedic," and "Liuliu Vision," with significant brand value and advantages due to effective brand communication and product performance [1] Financial Performance - In the latest quarterly report for Q3 2024, the company reported revenue of 6.028 billion yuan, a year-on-year decrease of 9.53%, and a net profit of 1.532 billion yuan, down 30.09% [2] - The sales gross margin for the company stands at 50.13% [2] - The PE ratio (TTM) for Yuyue Medical is 20.48, while the industry average is 45.22, indicating a significant valuation gap [2]